Searched for
ANTI ARTHRITIS DRUG
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Zydus Lifesciences gets USFDA nod for generic rheumatoid arthritis treatment drugZydus Lifesciences has gained the US Food and Drug Administration's (FDA) approval to produce and market its Indomethacin suppositories. Th...
- Europe eyes arthritis drug for Covid-19 casesEU drug regulator said that it was assessing an application to extend the use of tocilizumab for adults suffering from severe coronavirus i...
- Strides Pharma receives USFDA approval for Prednisone tabletsStrides Pharma Global Pte Limited, Singapore, has received approval for Prednisone tablets USP in the strengths of 10 mg and 20 mg from the...
- World Autoimmune Arthritis Day: Don't let pain dominate your life. Early treatment, lifestyle changes are keyRheumatoid arthritis affects about 1 in 100 Indians.
- Don't ignore joint pain with fever, fatigue: It can mean rheumatoid arthritisRheumatoid arthritis, an autoimmune disease, tends to affect women more than men.
- Unichem Labs gets USFDA nod for arthritis drugPiroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheum...
- Biologics enter top selling drugs’ listBiologics, also called biopharmaceuticals, have revolutionised treatment in chronic and serious illnesse and nudged traditional drugs out o...
- Suffering from post-viral arthritis? Physiotherapy, yoga can helpViral arthritis cases usually spring up around the months of June to October.
- Drink green tea to combat rheumatoid arthritisExisting drugs for rheumatoid arthritis are expensive and sometimes unsuitable for long-term use.
- Aurobindo gets USFDA nod for epilepsy, arthritis drugsLevetiracetam injection is used for treatment of partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, a...
- Heard on the Street: Fund stocks up Biocon on drug launch buzzA large fund house belonging to a business conglomerate has been accumulating biotechnology company Biocon over the past two weeks on drug ...
- J&J unit wins $1.67 billion verdict vs Abbott LabsA unit of Johnson & Johnson said Monday that a federal jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement s...
- Philippines orders Novartis to pull anti-arthritis drugPhilippine health regulators on Friday ordered Swiss pharmaceutical giant Novartis to pull the painkiller Lumiracoxib from the market amid ...
- Cadila gets FDA nod for arthritis drugDisease Modifying Anti-Rheumatic Drug is a medication for patients with Rheumatoid Arthritis that helps reduce pain and inflammation, preve...
- Biocon to invest dollar 10 mn on expansionLeading biotech firm, Biocon Ltd, said it will invest $10 million (about Rs 45 cr) in the next 12 months to expand its facilities.
- Biocon may launch new anti-arthritis drugLeading biotech company, Biocon Limited on Monday said it expects to launch a new anti-arthritis drug in the next 3-4 years in the market, ...
- Nicholas Piramal signs agreements with UK firmIn a filing on the Bombay Stock Exchange the company said the first agreement was related to Morvus platform technology .
Load More
